menu search

Exscientia stock surges on merck kgaa partnership

Exscientia PLC shares climbed as much as 30% in pre-market trading on Wednesday after the precision-medicine company announced a new, multi-year coll...

September 20, 2023, 9:13 am

Exscientia's stock rockets toward a record gain after ai-driven drug discovery collaboration with germany's merck kgaa

The U.S.-listed shares of Exscientia PLC EXAI soared 28.5% toward a record one-day gain, and enough to pace all premarket gainers on major U.S. exchan...

September 20, 2023, 7:50 am

Merck: secure a safe 8% annualized return for the next decade

Merck's strong performance in the past two years, driven by Keytruda and Lagevrio, has outperformed the market by an impressive 52%. MRK's acquisition...

September 20, 2023, 4:13 am

Acrivon therapeutics to highlight its acr-368 oncosignature test, used in ongoing phase 2 study to treat patients based on predicted sensitivity to monotherapy with its chk1/2 inhibitor acr-368, at th

WATERTOWN, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) — Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clini...

September 19, 2023, 8:32 pm

Cabaletta bio: how long can unique cell therapy developer's sensational bull run continue?

Cabaletta Bio stock has experienced a significant bull run, rising over 2,100% in the past year. The company's focus on autoimmune conditions with a v...

September 19, 2023, 4:56 am

Harpoon therapeutics announces first patients with small cell lung cancer dosed in hpn328 combination cohort

SOUTH SAN FRANCISCO, Calif., Sept. 15, 2023 (GLOBE NEWSWIRE) — Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-...

September 15, 2023, 11:15 am

Nvidia and amgen back ai drug developer generate:biomedicines' $273m financing

Generate:Biomedicines said it has raised $273 million to fund its pipeline of programs in preclinical and clinical development across ...

September 14, 2023, 11:29 am

Genelux corporation reports inducement grants under nasdaq listing rule 5635(c)(4)

WESTLAKE VILLAGE, Calif., Sept. 14, 2023 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-...

September 14, 2023, 11:00 am

Pharmadrug advances investigational cancer therapeutic pd-001 toward in human safety trials

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) said it continues to advance its patented reformulated enteric-coated version of orally bioavailable cepharanth...

September 14, 2023, 8:56 am

Moderna, inc. (mrna) r&d day and business updates (transcript)

Moderna, Inc. (NASDAQ:MRNA ) R&D Day and Business Updates September 13, 2023 1:00 PM ET Company Participants Stephane Bancel - CEO Stephen Hoge - Pres...

September 14, 2023, 1:29 am

Sensei biotherapeutics to present new preclinical data supporting mechanism of action, pharmacokinetic profile and safety characteristics for sns-101, a conditionally active vista-blocking antibody, a

BOSTON, Sept. 13, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-...

September 13, 2023, 11:30 am

Ideaya's triple threat: melanoma, money, and momentum

IDEAYA Biosciences specializes in precision oncology, has FDA clearance for a Phase 1/2 trial, and part...

September 13, 2023, 6:19 am

Poolbeg pharma talking to potential partners in the oncology arena as it expands scope of key asset

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) said is actively in discussions with prospective partners to further explore ...

September 13, 2023, 2:56 am

Io therapeutics, inc., announces publication of data on a novel compound promoting anti-cancer immune responses

SPRING, Texas, Sept. 12, 2023 (GLOBE NEWSWIRE) — Io Therapeutics, Inc., announced today the publication in Scientific Reports – Nature Publishing ...

September 12, 2023, 4:43 am

Pfizer inc. (pfe) management presents at morgan stanley 21st annual global healthcare conference (transcript)

Pfizer Inc. (NYSE:PFE ) Morgan Stanley 21st Annual Global Healthcare Conference September 11, 2023 12:15 PM ET Company Participants Angela Hwang - CCO...

September 11, 2023, 6:04 pm

Medigene ag to present at the baader investment conference 2023

Planegg/Martinsried, September 11, 2023. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an immuno-...

September 11, 2023, 12:30 pm

Rosen, trusted investor counsel, encourages rain oncology inc. investors to secure counsel before important september 12 deadline in securities class action – rain

NEW YORK, Sept. 08, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain ...

September 8, 2023, 10:16 pm

Hillstream biopharma to present at h.c. wainwright 25th annual global investment conference september 11-13

Management will present and hold virtual 1-on-1 meetings with institutional investors and analysts BRIDGEWATER, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) ...

September 8, 2023, 6:30 pm

Hillstream biopharma to present at h.c. wainwright 25th annual global investment conference september 11-13

BRIDGEWATER, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology compa...

September 8, 2023, 2:30 pm

Imunon to host virtual r&d day on september 14th beginning at 4:00 p.m. et

Program will feature members of IMUNON executive management along with key opinion leaders in immuno-oncology<...

September 7, 2023, 8:30 pm


Search within

Pages Search Results: